Skip to main content

MedPath Trial Home

Organizations News Research

Data Sources:ClinicalTrials.govEU CTRFDAEMANMPATGAHealth CanadaWHO ICTRP

MedPath Trial Home

Search trials. Track pipelines. Understand approvals. With AI-powered intelligence for clinical research.

Product

Clinical Trials
Drug Intelligence
Global Approvals
AI Research
Pricing

Resources

FAQ
Search

Company

News
About
Contact

Legal

Privacy Policy
Terms of Service

Disclaimer: This website provides information retrieval and data analysis services. The content does not constitute medical advice. Eligibility assessments are for reference only and should not replace consultation with qualified healthcare professionals. Data is sourced from public registries and regulatory agencies; MedPath does not guarantee completeness or accuracy. Always verify information with primary sources.

© 2026 MedPath Trial. All rights reserved.

We value your privacy

We use cookies to analyze site traffic and improve your experience. See our Privacy Policy.

思他宁 - NMPA Drug Approval Details

Approvals/NMPA/Somatostatin for Injection

Approved

化学药品

Somatostatin for Injection

Unknown🇨🇳 National Medical Products Administration

Approval Date: Sep 15, 2025
Approval ID: 887yJs2FWmF
Company: Unknown
Type: 化学药品

Approval Details

Approval Id: 887yJs2FWmF
Approval Number: 国药准字HJ20140873
Generic Name: 注射用生长抑素
Generic Name En: Somatostatin for Injection
Trade Name: 思他宁
Drug Type: 化学药品
Dosage Form: 注射剂
Strength: 3mg
Reg Date: 2025-09-15
Expired Date: 2030-09-14
Production Company Name: ALFASIGMA SPA
Production Company Detail Path: /organization/alfasigma-spa

Approved

Quick Info

Agency

NMPA

Country

🇨🇳

Approval Date

Sep 15, 2025

Approval ID

887yJs2FWmF

Type

化学药品

Back to NMPA Approvals